HIV Prevention Readiness Assessment

JavaScript isn't enabled in your browser, so this file can't be opened. Enable and reload.

This assessment measures clinical knowledge, communication confidence, and practice-level barriers to HIV prevention service delivery.

Demographics

6 questions

Current Role/Job Title

Practice Setting

Hospital/Health-System Pharmacy

Ambulatory Care/Clinic Pharmacy

Independent Community Pharmacy

Chain Community Pharmacy

Public Health Department/FQHC/Community Health Center

Academia

Other:

Clear selection

Years of Professional Experience

0 - 2 years

3 - 5 years

6 - 10 years

11 - 15 years

16 - 20 years

21+ years

Clear selection

Geographic Location

Please indicate your race/ethnicity (select all that apply)

American Indian or Alaska Native

Asian

Black or African American

Hispanic/Latino

Middle Eastern or North African

Native Hawaiian or Other Pacific Islander

White

Prefer not to answer

Other:

Previous HIV Prevention Training

None

Attended at least 1 CPE on HIV prevention in the last 2 years

Attended multiple trainings on HIV prevention (please list approximate #)

Completed an HIV‐focused certification program (e.g., AAHIVP, etc.)

Clear selection

Estimated Number of PLWH (People Living with HIV) Seen in Last 6 Months

0 to 20

21 to 40

41 to 60

61 to 80

81 to 100

100+

Clear selection

Baseline knowledge of HIV PrEP/PEP

5 questions

Which of the following situations may indicate that a patient would benefit from HIV pre-exposure prophylaxis (PrEP)?

Recent diagnosis of a sexually transmitted infection (STI)

Sharing injection drug equipment

Planning pregnancy with a partner living with HIV

All of the above

Clear selection

Which of the following PrEP medications is NOT currently FDA-approved for use in people assigned female at birth (AFAB)?

Truvada (emtricitabine/tenofovir disoproxil fumarate)

Descovy (emtricitabine/tenofovir alafenamide)

Apretude (cabotegravir long-acting injection)

Vocabria (cabotegravir)

None of the above

Clear selection

What is the recommended time window for initiating post-exposure prophylaxis (PEP) after potential HIV exposure?

Within 72 hours

Within 7 days

Within 24 hours only

Clear selection

What is a key difference between oral PrEP and PEP?

PEP is used after a known exposure and must be taken within 72 hours

PrEP is taken once after exposure and protects immediately

PEP is only for people living with HIV

Oral PrEP must always be taken for life

Clear selection

A patient on PrEP expresses interest in pregnancy. What should you do?

Refer to reproductive health services and continue Truvada if appropriate

Immediately discontinue PrEP

Switch to injectable PrEP without counseling

Tell them to wait until after delivery

Clear selection

For each of the following, please rate how much you agree or disagree with the following statements about PrEP/PEP implementation in your training or practice setting

(1 = Strongly disagree, 4 = Strongly agree):

1: Strongly disagree

2: Disagee

3: Agree

4: Strongly agree

I have received enough formal training on PrEP/PEP

I know how to assess HIV risk effectively

I am confident in identifying patients who are eligible for PrEP/PEP

I am aware of the updated guidelines for PrEP/PEP utilization

I can identify when a patient may benefit from switching PrEP modalities (e.g., oral to injectable)

Confidence in HIV prevention conversations and referrals

5 questions

Do you know where to refer patients who are interested in starting HIV PrEP or PEP?

Yes, I know multiple clinics or providers and feel confident referring patients

Somewhat, I know of a few providers but not a full network

No, I am unfamiliar who to refer patients to

Clear selection

What is the biggest barrier you face in providing PrEP at your practice?

Navigating insurance and cost

Accessibility to patient’s desired method of PrEP

Patient’s concern with stigma

Lack of PrEP education

Other:

Clear selection

When thinking about starting a conversation about HIV PrEP with a patient, which of the following challenges, if any, make it difficult for you to do so?

Concern about making patients uncomfortable

Limited training or guidance on how to start the conversation

No established workflow or protocol in my practice setting

Unsure of next steps after identifying a patient who could benefit

My role is restricted by scope-of-practice or institutional policies

None of the above/I don’t experience any barriers

Other:

What kind of tools, training, or resources would help you feel more confident offering PrEP/PEP support?

How confident are you in your ability to:

For each of the following, select your confidence level: (1 = Not at all confident, 4 = Very confident)

1: Not at all confident

2: Somewhat confident

3: Confident

4: Very confident

Refer patients to culturally competent PrEP/PEP providers in your area

Comfortably discuss sexual health with patients under 17 years old.

Respond supportively when a patient shares experiences of sexual trauma or stigma

Discuss PrEP with patients who use drugs (PWUD) in a supportive, stigma-free manner

Clear selection

Submit

Clear form

Never submit passwords through Google Forms.

This form was created inside of NPhA.

Does this form look suspicious? Report

Forms